Font Size: a A A
Keyword [?-agonist]
Result: 41 - 60 | Page: 3 of 4
41. Design, Synthesis And Evaluation Of Fused Heteropyrimidine Derivatives As GPR119 Agonist For Treatment Of Type 2 Diabetes
42. Drug Carrier Nanosystem Based On Polymeric Copper C Helator For Combining Antiangiogenesis And Immunotherapy For Targeted Treatment Of Breast C Ancer
43. An Optimized Method For The Analysis Of Beta-agonist Residues In Pork Based On Lipidomics
44. Investigation On Tumor Microenvironment-responsive Nano Drug Delivery System For Enhancing Immunotherapy
45. Synthesis Process Optimization Of A3 Adenosine Receptor Agonist CF102 And Synthesis Of BMN-673 Analogues
46. Primary Study On Relocalization Of PPAR? Agonist Bezafibrate And Anti-lung Adenocarcinoma Activity
47. Development Of Electrochemical Nano-immunosensor For Multi-residue Detection Of ?-agonists
48. Research On ?2AR Agonist Safety Warning Model Based On Molecular Simulation And Its Multi-residue Electrochemical Biosensor
49. Pulsed short-wave diathermy and its influence on a proprioceptive neuromuscular facilitation stretching protocol of the hamstrings
50. Determination of antibiotic, beta-agonist, and non-steroidal anti-inflammatory drug residues in ground beef from USDA certified organic, natural, conventional, and market cow and bull sources
51. Preparation And Immunological Evaluation Of Synthetic Vaccine Based On INKT Cell Agonist
52. Preparation And Research Of Acetaldehyde Dehydrogenase Agonist 2 Alda-1 Nanoemulsion
53. Construction Of Irreversible Epidermal Growth Factor Receptor Inhibitors And 4D-QSAR Study Of Cannabinoid Receptor Inverse Agonists
54. Study On The Formulation And Anti-breast Cancer Effect By PD-L1 Targeting Nanoliposomes Delivery Of STING Agonist
55. A New Thoyrid Hormone Receptor-? Agonist CS26087 Improves Non-Alcoholic Fatty Liver Disease
56. The Investigation On The Interaction Mechanism Between ?2 Adrenergic Receptor And Ligands And Virtual Screening Of ? Agonists
57. Resource Utilization Of A Steroidal Waste And Preliminary Investigation Of Some Cholesteroids As SHP-1 Agonist
58. Synthesis And Immunological Activity Of Fully Synthetic Two-component Anti-tumor Vaccines With ?GalCer As An Adjuvant
59. Design,synthesis And Bioactivity Evaluation Of Novel ALDH2 Allosteric Activators
60. Synthesis Process Optimization Of Obeticholic Acid And Pyridoxal Phosphate
  <<First  <Prev  Next>  Last>>  Jump to